Thanks Neuro. >>> (there is some question as to whether there is a placebo effect in apnea trials) <<<
That's interesting, whether or not there can be a placebo effect while someone is asleep?
But I've personally written off the significance of the SA trial altogehter, unless by some miracle they can get a bunch more patients through the 3rd PSG before the interim analysis at month's end. If they could get 10 completers or more, that would be great, but for now I'm not counting on anything useful coming out of the trial.
To boost enrollmet in the next several weeks, why not pull out all the stops and pay the subjects A LOT more money if they get through the full 3 PSGs. Like a $10,000 or $15,000 bonus for any subjects who make it through the 3rd PSG. For Cortex that would be money well spent if it would ensure at least some useful data from the trial.